Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

On September 17, 2026, Abbott Laboratories’ board of directors declared a quarterly common dividend of USD 0.63 per share, ...

View Abbott Laboratories ABT stock quote prices, financial information, real-time forecasts, and company news from CNN.

Valued at a market cap of $194.6 billion, Abbott Laboratories (ABT) is a global healthcare company that discovers, develops, manufactures, and sells a wide range of healthcare products across various ...

Analysts keep raising their price targets on this 54-year dividend raiser. Here are the reasons behind the newfound confidence.

Shares of Abbott Laboratories (ABT) gained on Wednesday after Baird initiated coverage with an Outperform rating and a $121 price target, citing a stable growth trajectory for the MedTech company ...

Financial information summarized by Zonebourse indicates that Abbott Laboratories most recently reported group net income of 7.07 billion in its latest fiscal year, up from 6.93 billion in the ...

Abbott trades at a cheaper valuation but carries higher litigation risk, while J&J boasts superior profitability despite a pending talc settlement.

Abbott Laboratories is now fairly valued after a 26% decline from its 2021 highs, but I maintain a Hold rating. ABT's Q1/26 saw 7.8% revenue growth, with medical devices leading, but operating income ...